Gelonghui April 25丨Olin Biotechnology (688319.SH) announced the first quarter report of 2024. During the reporting period, the company achieved revenue of 70.8 million yuan, a year-on-year increase of 5.87%; net profit loss attributable to the parent company was 25.9969 million yuan; excluding non-profit Net profit loss was 27.84 million yuan.
Basic earnings per share -0.0641 yuan.